Cancer screening accuracy determines survival outcomes, yet most centers still apply one-size-fits-all protocols that miss high-risk individuals while over-testing others. Personalized risk assessment transforms screening from population-level guesswork into precision medicine tailored to individual genetics, family history, and exposure patterns. TL;DR Multicancer early detection (MCED) blood tests can identify cancer signals 12-18 months before tumors form, but produce a 25